Literature DB >> 4812755

Proceedings: The response of breast cancer patients with bone pain to L-dopa.

J P Minton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812755     DOI: 10.1002/1097-0142(197402)33:2<358::aid-cncr2820330209>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Morphine sulfate stimulates the adenylate cyclase in mouse caudate nuclei.

Authors:  L C Tang; G C Cotzias
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.

Authors:  E Engelsman; J C Heuson; J Blonk Van Der Wijst; A Drochmans; H Maass; F Cheix; L G Sobrinho; H Nowakowski
Journal:  Br Med J       Date:  1975-06-28

3.  LevoDopa test and estrogen receptor assay in prognosticating responses of patients with advanced cancer of the breast to endocrine therapy.

Authors:  G H Sasaki; B S Leung; W S Fletcher
Journal:  Ann Surg       Date:  1976-04       Impact factor: 12.969

Review 4.  Endocrine therapy for advanced breast cancer: a review.

Authors:  H B Muss
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Intractable pain with breast cancer.

Authors:  C P Watson; R J Evans
Journal:  Can Med Assoc J       Date:  1982-02-01       Impact factor: 8.262

6.  Anticholinergic-induced analgesia: possible role for the cholinergic system in abnormal sensory symptoms in Parkinson's disease.

Authors:  R Sandyk
Journal:  Postgrad Med J       Date:  1986-08       Impact factor: 2.401

7.  Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.

Authors:  M Bontenbal; J A Foekens; S W Lamberts; F H de Jong; W L van Putten; H J Braun; J T Burghouts; G H van der Linden; J G Klijn
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.